Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for Prevention of Muscle Mass Loss in Immobilized Subjects
NCT01987570Phase 3Completed
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Apr 2012
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of allopurinol in muscle atrophy, sponsored by Health Research Institute Hospital La Fe. Started Apr 2012; status: completed.
02
Drugs
allopurinol
03
Conditions
muscle atrophy
Beyond the preview
Go deeper on NCT01987570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987570.